The platform consists of four tools -- Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals -- for the IVD manufacturer and the lab, providing an end-to-end platform that streamlines workflows, according to BrightInsight.

"The BrightInsight Connected Diagnostics Platform is a one-stop solution for in vitro diagnostics manufacturers to maximize workflow and visibility, manage devices more efficiently and reduce costs," Dr. Kal Patel, CEO and cofounder of the San Jose, CA-based firm, said in a statement.

LumiraDx to discuss microfluidic technology at AACC
LumiraDx announced that it will host an industry workshop at AACC 2022 on Wednesday, describing the impact of its microfluidic technology on lateral-flow...

Cytovale to present new data on rapid sepsis test at AACC
Cytovale said Monday that it will present new data at AACC 2022 about its 10-minute IntelliSep test for sepsis and its associated system.

Companies announce new products ahead of AACC 2022
Several companies have announced the launch of laboratory diagnostic products in advance of AACC 2022.

DiaSorin nabs FDA clearance for infectious disease blood test
Saluggia, Italy-based DiaSorin on Friday announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for the Liaison MeMed BV, its...

Survey finds low morale among lab professionals
Lighthouse Lab Services on Wednesday announced the results of its first wage and morale survey of medical laboratory professionals, saying that despite...

Beckman, Scopio to partner on blood smear platforms
Beckman Coulter Diagnostics on Wednesday announced that it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral...

AACC sees rise in impact of medical laboratory journal
AACC recently announced that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports.